Page 10 - Flipbook
P. 10

1 in 10 Men with mCRPC have Germline Mutations







                    Distribution of presumed pathogenic                                        • Inherited germline DDR mutations

                                 germline mutations
                                                                                                       • mCRPC: 11.8% (82/692)

                                                                                                       • Localized disease: 4.6% (23/499)
                                     RAD51C 1%
                           MSH6 1%                     MRE11A 1%
                           MSH2 1%
                                                         BRIP1 1%                                             Presumed pathogenic germline mutations
                         GEN1 2%                         FAM175A 1%
                      PMS2 2%                                                                                            in metastatic cases (N = 692)
                NBN 2%
                ATR 2%                                                                                    Gene                      No. of Mutations                     % of Men
         RAD51D 4%


           PALB2 4%                                                                                       BRCA2                               37                             5.35

                                                     BRCA2 44%
                          BRCA1 7%                                                                         ATM                                11                             1.59



                            CHEK2 12%                                                                    CHEK2*                               10                             1.87


                                                                                                          BRCA1                               6                              0.87
                                          ATM 13%

                                                                                                    *n = 534; data censored for metastatic cases with inadequate sequencing


      DDR, DNA damage response
      Pritchard CC et al. NEJM 2016;375:443-53.
   5   6   7   8   9   10   11   12   13   14   15